Form 4: Ekso Bionics Director Corinna Lathan Reports Acquisition of 78,217 Restricted Stock Units

Director Corinna Lathan reports acquisition of 78,217 restricted stock units in Ekso Bionics Holdings, Inc. following the company's annual meeting.

Summary

• Corinna Lathan, a director of Ekso Bionics Holdings, Inc., reported the acquisition of 78,217 restricted stock units (RSUs) on June 6, 2024.
• The RSUs were granted as part of an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021.
• Each RSU represents the economic equivalent of one share of EKSO common stock and will be settled in shares upon vesting.
• The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
• Following the transaction, Lathan beneficially owns 226,207 shares of common stock, including 78,217 unvested RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.

Industry Context

This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

Keywords

EKSO Bionics, Director, Corinna Lathan, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, Securities, Equity